M21-1 and 38 CFR changes, week of Dec 4, 2017

Added

• 7008 Hyperthyroid heart disease.
• | Rate under the appropriate cardiovascular diagnostic code, depending on particular findings.
• 82 FR 50804, Dec.

and 2 more added passages

Removed

• Link to an amendment published at 82 FR 50804, Nov.
• 7008 Hyperthyroid heart disease:
• Include as part of the overall evaluation for hyperthyroidism under DC 7900.
• However, when atrial fibrillation is present, hyperthyroidism may be evaluated either under DC 7900 or under DC 7010 (supraventricular arrhythmia), whichever results in a higher evaluation.

and 2 more removed passages

Added

• 7900 Hyperthyroidism, including, but not limited to, Graves' disease:
• For six months after initial diagnosis | 30
• Thereafter, rate residuals of disease or complications of medical treatment within the appropriate diagnostic code(s) within the appropriate body system.
• | Note (1):
• If hyperthyroid cardiovascular or cardiac disease is present, separately evaluate under DC 7008 (hyperthyroid heart disease).
• | Note (2):
• Separately evaluate eye involvement occurring as a manifestation of Graves' Disease as diplopia (DC 6090);
• impairment of central visual acuity (DCs 6061-6066);

and 85 more added passages

Removed

• Link to an amendment published at 82 FR 50804, Nov.
• 7900 Hyperthyroidism |
• Thyroid enlargement, tachycardia (more than 100 beats per minute), eye involvement, muscular weakness, loss of weight, and sympathetic nervous system, cardiovascular, or astrointestinal symptoms | 100
• Emotional instability, tachycardia, fatigability, and increased pulse pressure or blood pressure | 60
• Tachycardia, tremor, and increased pulse pressure or blood pressure | 30
• Tachycardia, which may be intermittent, and tremor, or;
• continuous medication required for control | 10

and 72 more removed passages

Added

• Link to an amendment published at 82 FR 57835, Dec.

and 1 more added passages